Scarica l'app Stockscreener
100.42
2.74%
2.68
Dopo l'orario di chiusura:
100.27
-0.15
-0.15%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LRCX Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$97.74
Aprire:
$97.66
Volume 24 ore:
8.81M
Relative Volume:
0.82
Capitalizzazione di mercato:
$127.09B
Reddito:
$18.44B
Utile/perdita netta:
$5.36B
Rapporto P/E:
24.14
EPS:
4.16
Flusso di cassa netto:
$5.41B
1 W Prestazione:
-3.53%
1M Prestazione:
+2.04%
6M Prestazione:
+31.37%
1 anno Prestazione:
+31.36%
Intervallo 1D:
$97.16
$101.11
Intervallo di 1 settimana:
$94.11
$102.69
Portata 52W:
$56.32
$108.02
Lam Research Corp Stock (LRCX) Company Profile
Nome
Lam Research Corp
Settore
Industria
Telefono
(510) 659-0200
Indirizzo
4650 CUSHING BLVD, FREMONT, CA
Confronta LRCX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LRCX
Lam Research Corp
|
100.42 | 122.80B | 18.44B | 5.36B | 5.41B | 4.16 |
|
ASML
Asml Holding Nv
|
753.43 | 285.40B | 34.96B | 10.23B | 10.02B | 26.11 |
|
AMAT
Applied Materials Inc
|
158.24 | 125.53B | 28.61B | 6.83B | 5.82B | 8.39 |
|
KLAC
Kla Corp
|
873.29 | 111.69B | 12.15B | 4.06B | 3.74B | 30.39 |
|
TER
Teradyne Inc
|
119.39 | 19.19B | 2.83B | 469.17M | 568.90M | 2.89 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-14 | Ripresa | Erste Group | Buy |
| 2025-07-31 | Downgrade | Summit Insights | Buy → Hold |
| 2025-07-31 | Reiterato | TD Cowen | Buy |
| 2025-07-10 | Iniziato | Goldman | Buy |
| 2025-04-24 | Reiterato | TD Cowen | Buy |
| 2025-03-20 | Ripresa | Oppenheimer | Outperform |
| 2025-02-20 | Aggiornamento | Susquehanna | Neutral → Positive |
| 2025-01-30 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2025-01-30 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-17 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-15 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-12-17 | Iniziato | Cleveland Research | Neutral |
| 2024-08-01 | Reiterato | TD Cowen | Buy |
| 2024-05-13 | Iniziato | Jefferies | Buy |
| 2024-04-25 | Reiterato | TD Cowen | Buy |
| 2024-04-19 | Aggiornamento | B. Riley Securities | Neutral → Buy |
| 2024-04-18 | Reiterato | Needham | Buy |
| 2024-04-16 | Iniziato | Evercore ISI | Outperform |
| 2024-04-11 | Ripresa | Deutsche Bank | Hold |
| 2024-01-25 | Reiterato | TD Cowen | Outperform |
| 2024-01-23 | Iniziato | Cantor Fitzgerald | Neutral |
| 2023-12-12 | Downgrade | Deutsche Bank | Buy → Hold |
| 2023-12-08 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-22 | Iniziato | Redburn Atlantic | Buy |
| 2023-10-17 | Iniziato | Raymond James | Outperform |
| 2023-10-13 | Aggiornamento | Needham | Hold → Buy |
| 2023-09-15 | Iniziato | Wolfe Research | Outperform |
| 2023-07-24 | Reiterato | Mizuho | Buy |
| 2023-07-24 | Aggiornamento | Stifel | Hold → Buy |
| 2023-04-20 | Reiterato | Berenberg | Buy |
| 2023-04-20 | Reiterato | Evercore ISI | Outperform |
| 2023-04-20 | Reiterato | JP Morgan | Overweight |
| 2023-04-20 | Reiterato | Jefferies | Buy |
| 2023-04-20 | Reiterato | Mizuho | Buy |
| 2023-04-20 | Reiterato | Stifel | Hold |
| 2023-04-20 | Reiterato | Wells Fargo | Equal Weight |
| 2023-03-13 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-01-18 | Ripresa | Stifel | Hold |
| 2022-12-12 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2022-10-20 | Reiterato | B. Riley Securities | Neutral |
| 2022-10-20 | Reiterato | BofA Securities | Buy |
| 2022-10-20 | Reiterato | DA Davidson | Neutral |
| 2022-10-20 | Reiterato | Evercore ISI | Outperform |
| 2022-10-20 | Reiterato | JP Morgan | Overweight |
| 2022-10-20 | Reiterato | Jefferies | Buy |
| 2022-10-20 | Aggiornamento | Summit Insights | Hold → Buy |
| 2022-10-20 | Reiterato | Wells Fargo | Equal Weight |
| 2022-07-25 | Downgrade | Barclays | Overweight → Equal Weight |
| 2022-06-15 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2022-01-27 | Reiterato | Barclays | Overweight |
| 2022-01-27 | Reiterato | Deutsche Bank | Hold |
| 2022-01-27 | Reiterato | Evercore ISI | Outperform |
| 2022-01-27 | Reiterato | Stifel | Buy |
| 2022-01-27 | Reiterato | Susquehanna | Neutral |
| 2022-01-27 | Reiterato | UBS | Buy |
| 2022-01-26 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-01-12 | Reiterato | Barclays | Overweight |
| 2022-01-10 | Reiterato | BofA Securities | Buy |
| 2022-01-05 | Ripresa | Jefferies | Buy |
| 2021-12-15 | Reiterato | Deutsche Bank | Hold |
| 2021-10-21 | Reiterato | B. Riley Securities | Buy |
| 2021-10-21 | Downgrade | Summit Insights | Buy → Hold |
| 2021-10-15 | Iniziato | Piper Sandler | Neutral |
| 2021-09-14 | Downgrade | Susquehanna | Positive → Neutral |
| 2021-09-07 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| 2021-07-29 | Reiterato | Mizuho | Buy |
| 2021-07-29 | Reiterato | Stifel | Buy |
| 2021-07-29 | Reiterato | UBS | Buy |
| 2021-07-29 | Reiterato | Wells Fargo | Equal Weight |
| 2021-03-31 | Iniziato | Bernstein | Outperform |
| 2021-01-28 | Reiterato | Cowen | Outperform |
| 2021-01-08 | Downgrade | Needham | Buy → Hold |
| 2020-12-17 | Downgrade | Deutsche Bank | Buy → Hold |
| 2020-10-22 | Reiterato | Goldman | Buy |
| 2020-10-22 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2020-10-22 | Reiterato | Mizuho | Buy |
| 2020-10-22 | Reiterato | Morgan Stanley | Overweight |
| 2020-10-22 | Reiterato | RBC Capital Mkts | Outperform |
| 2020-10-22 | Reiterato | Stifel | Buy |
| 2020-10-22 | Reiterato | UBS | Buy |
| 2020-09-21 | Aggiornamento | Stifel | Hold → Buy |
| 2020-07-30 | Reiterato | Cowen | Outperform |
| 2020-07-21 | Aggiornamento | B. Riley FBR | Neutral → Buy |
| 2020-06-22 | Downgrade | Stifel | Buy → Hold |
| 2020-06-16 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-26 | Iniziato | Barclays | Overweight |
| 2020-04-23 | Reiterato | Needham | Buy |
| 2020-04-08 | Iniziato | Exane BNP Paribas | Outperform |
| 2020-04-03 | Aggiornamento | Nomura | Neutral → Buy |
| 2020-04-02 | Downgrade | DA Davidson | Buy → Neutral |
| 2020-03-27 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2020-03-27 | Aggiornamento | UBS | Sell → Buy |
Mostra tutto
Lam Research Corp Borsa (LRCX) Ultime notizie
OMERS ADMINISTRATION Corp Cuts Position in Lam Research Corporation $LRCX - MarketBeat
Landscape Capital Management L.L.C. Trims Stake in Lam Research Corporation $LRCX - MarketBeat
Kodai Capital Management LP Acquires Shares of 505,987 Lam Research Corporation $LRCX - MarketBeat
Panagora Asset Management Inc. Trims Position in Lam Research Corporation $LRCX - MarketBeat
Is Lam Research Stock Outperforming the Dow? - Yahoo Finance
Vident Advisory LLC Grows Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
Trend analysis for Lam Research Corporation this weekQuarterly Portfolio Review & Fast Exit and Entry Trade Guides - Newser
Itau Unibanco Holding S.A. Has $1.54 Million Stake in Lam Research Corporation $LRCX - MarketBeat
Lansforsakringar Fondforvaltning AB publ Sells 8,816 Shares of Lam Research Corporation $LRCX - MarketBeat
When is the best time to exit Lam Research CorporationJuly 2025 Spike Watch & High Return Trade Opportunity Guides - Newser
Trexquant Investment LP Has $52.23 Million Stock Position in Lam Research Corporation $LRCX - MarketBeat
Parnassus Investments LLC Reduces Position in Lam Research Corporation $LRCX - MarketBeat
Jump Financial LLC Lowers Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
Multi asset correlation models including Lam Research Corporation2025 Retail Activity & Fast Gain Swing Trade Alerts - Newser
Key metrics from Lam Research Corporation’s quarterly dataDividend Hike & Long-Term Growth Plans - Newser
Is Lam Research Corporation stock poised for growthInsider Buying & High Conviction Investment Ideas - Newser
Using Ichimoku Cloud for Lam Research Corporation technicalsJuly 2025 Market Mood & Risk Controlled Daily Trade Plans - Newser
Smart tools for monitoring Lam Research Corporation’s price actionWeekly Investment Report & Fast Moving Trade Plans - Newser
Detecting support and resistance levels for Lam Research CorporationMarket Performance Report & Fast Gain Stock Trading Tips - Newser
What indicators show strength in Lam Research CorporationJuly 2025 Update & Verified Momentum Watchlists - Newser
Erste Group Resumes Coverage of Lam Research (LRCX) Stock with a Buy - Yahoo Finance
How moving averages guide Lam Research Corporation tradingMarket Movement Recap & Free Weekly Watchlist of Top Performers - Newser
Canada Pension Plan Investment Board Buys 1,077,487 Shares of Lam Research Corporation $LRCX - MarketBeat
Momentum divergence signals in Lam Research Corporation chartGap Down & Low Drawdown Momentum Ideas - Newser
Lam Research Corporation (NASDAQ:LRCX) Receives $107.30 Average Target Price from Analysts - MarketBeat
Why Lam Research Stock Crumbled by 3% Today - The Motley Fool
Is now a turning point for Lam Research CorporationDividend Hike & Accurate Entry/Exit Alerts - Newser
Why Lam Research Stock Is Down 3% In Today’s Premarket - Stocktwits
Why Lam Research (LRCX) Stock Is Falling Today - Yahoo Finance
Flputnam Investment Management Co. Purchases 4,823 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Shares Acquired by Point72 Italy S.r.l. - MarketBeat
Point72 Europe London LLP Lowers Holdings in Lam Research Corporation $LRCX - MarketBeat
US Equipment Makers to See Reduced China Sales Amid Licensing Changes - AInvest
Evergreen Capital Management LLC Purchases 5,130 Shares of Lam Research Corporation $LRCX - MarketBeat
Tema Etfs LLC Grows Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corp Azioni (LRCX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Lam Research Corp Azioni (LRCX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Varadarajan Seshasayee | Senior Vice President |
Feb 20 '25 |
Sale |
90.00 |
110,080 |
9,907,200 |
179,084 |
1.27%
0.20%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):